Polyalanine Tails: A Novel Type of Protein Modification Implicated in Neurodegeneration
聚丙氨酸尾:一种与神经变性有关的新型蛋白质修饰
基本信息
- 批准号:10521560
- 负责人:
- 金额:$ 75.12万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-08-01 至 2027-05-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAlanineAmyotrophic Lateral SclerosisBacteriaBasic ScienceBehavioralBindingBiochemicalBiological AssayBiologyC-terminalCell modelCellsComplexDataDefectDevelopmentDiseaseEthylnitrosoureaEtiologyExhibitsFunctional disorderFundingGenesGoalsHistopathologyHumanInduced MutationInheritedInterventionInvestigationKnowledgeLeadLightMammalian CellMediatingModelingModificationMolecularMotorMotor Neuron DiseaseMotor NeuronsMouse StrainsMusMutationNerve DegenerationNeurodegenerative DisordersNeuromuscular DiseasesNeuromuscular conditionsNeuronsNitrosourea CompoundsNuclear ExportOrthologous GeneParalysedPatientsPhenocopyPhenotypePlayPost-Translational Protein ProcessingPrevalenceProteinsProteolysisPublic HealthQuality ControlReportingResearchResearch ProposalsRibosomesRoleSocietiesSpinal CordSystemTailTestingTissuesToxic effectTranslationsVariantWorkYeastsaging populationbasecausal variantcofactorcytotoxicitydesignearly onsetfitnesshuman diseaseinsightloss of functionmouse modelmutantnervous system disorderneurodegenerative phenotypenovelnovel therapeuticspolyalaninepolypeptideprotein aggregationsporadic amyotrophic lateral sclerosistherapeutically effectiveubiquitin-protein ligase
项目摘要
Among the costliest diseases to society, and with rising prevalence in an aging population, neurodegenerative
diseases pose a public health challenge. However, there are few options available for their treatment, and
without pathomechanisms being sufficiently elucidated, one's ability to generate a rationale for interventions is
greatly limited. Our studies are expected to address this barrier by establishing new etiological factors and
molecular mechanisms of mammalian neurodegeneration. One such mechanism is Ribosome-associated
Quality Control (RQC), that mediates the degradation of incomplete polypeptides produced by ribosomes that
stall during translation. Key factors working in RQC are the Ltn1/Listerin E3 ubiquitin ligase and its partner,
NEMF (Rqc2 in yeast). PI Joazeiro has previously found that Ltn1 mutation causes neurodegeneration in mice.
PI Cox has more recently identified two independent mutations in mouse Nemf causing motor neuron disease
and used this to knowledge to identify previously undiagnosed patients with a similar neuromuscular condition
that inherited causative mutations in the human NEMF gene. In several ways, Ltn1-ENU and Nemf-ENU mice
phenocopy each other, thus strengthening the connection between RQC dysfunction and neurodegeneration.
The proposed studies are aimed at understanding molecular mechanisms underlying neurodegeneration
caused by NEMF loss of function. We focus our analyses on a recently-discovered activity of NEMF that is
conserved from bacteria to humans–the modification of aberrant nascent chains with C-terminal Alanine tails
that have a proteolytic function. Based on our preliminary data, we hypothesize that NEMF-mediated Ala tailing
protects neurons against degeneration. Results of these studies are expected to provide critical understanding
of how defects in protein quality control lead to neurological disease.
在社会代价最高的疾病中,随着老龄化人口患病率的上升,神经退行性疾病
疾病对公共卫生构成了挑战。然而,治疗他们的选择很少,而且
在没有充分阐明发病机制的情况下,一个人产生干预的理由的能力是
非常有限。我们的研究有望通过建立新的病因和
哺乳动物神经退变的分子机制。一种这样的机制是核糖体相关的
质量控制(RQC),调节核糖体产生的不完全多肽的降解
在转换过程中停顿。在RQC中起作用的关键因素是Ltn1/Listerin E3泛素连接酶及其合作伙伴,
NEMF(酵母中的Rqc2)。Pi Joazeiro此前曾发现,Ltn1突变会导致小鼠的神经退化。
皮考克斯最近在导致运动神经元疾病的小鼠NEMF中发现了两个独立的突变
并利用这一知识来识别之前未被诊断出有类似神经肌肉疾病的患者
它遗传了人类NEMF基因的致病突变。在几个方面,Ltn1-enu和Nemf-enu小鼠
表型相互复制,从而加强RQC功能障碍和神经退行性变之间的联系。
拟议的研究旨在了解神经退行性变的分子机制。
由NEMF功能丧失所致。我们的分析集中在最近发现的NEMF活动上,即
从细菌到人类的保守性-C-末端丙氨酸尾巴对异常新生链条的修饰
具有蛋白质分解功能的物质。根据我们的初步数据,我们假设NEMF介导的ALA拖尾
保护神经元免受退化。这些研究的结果有望提供批判性的理解
蛋白质质量控制缺陷如何导致神经疾病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GREGORY A. COX其他文献
GREGORY A. COX的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GREGORY A. COX', 18)}}的其他基金
CAT-tails: A Novel Type of Protein Modification Implicated in Neurodegeneration
CAT-tails:一种与神经退行性疾病有关的新型蛋白质修饰
- 批准号:
9910468 - 财政年份:2017
- 资助金额:
$ 75.12万 - 项目类别:
CAT-tails: A Novel Type of Protein Modification Implicated in Neurodegeneration
CAT-tails:一种与神经退行性疾病有关的新型蛋白质修饰
- 批准号:
9366361 - 财政年份:2017
- 资助金额:
$ 75.12万 - 项目类别:
Short Course on Medical and Experimental Mammalian Genetics
医学和实验哺乳动物遗传学短期课程
- 批准号:
8837663 - 财政年份:2014
- 资助金额:
$ 75.12万 - 项目类别:
Human and Mammalian Genetics and Genomics: the McKusick Short Course
人类和哺乳动物遗传学和基因组学:麦库西克短期课程
- 批准号:
10610866 - 财政年份:2014
- 资助金额:
$ 75.12万 - 项目类别:
Human and Mammalian Genetics and Genomics: the McKusick Short Course
人类和哺乳动物遗传学和基因组学:麦库西克短期课程
- 批准号:
9903418 - 财政年份:2014
- 资助金额:
$ 75.12万 - 项目类别:
Human and Mammalian Genetics and Genomics: the McKusick Short Course
人类和哺乳动物遗传学和基因组学:麦库西克短期课程
- 批准号:
10377470 - 财政年份:2014
- 资助金额:
$ 75.12万 - 项目类别:
Imaging Circuit Change in the Motor Cortex of Mouse Model of ALS
ALS 小鼠模型运动皮层的成像电路变化
- 批准号:
8605941 - 财政年份:2013
- 资助金额:
$ 75.12万 - 项目类别:
Imaging Circuit Change in the Motor Cortex of Mouse Model of ALS
ALS 小鼠模型运动皮层的成像电路变化
- 批准号:
8510018 - 财政年份:2013
- 资助金额:
$ 75.12万 - 项目类别:
Genetic Control of Phospholipid Biosynthesis and Muscular Dystrophy
磷脂生物合成和肌营养不良症的遗传控制
- 批准号:
8130650 - 财政年份:2007
- 资助金额:
$ 75.12万 - 项目类别:
Genetic Control of Phospholipid Biosynthesis and Muscular Dystrophy
磷脂生物合成和肌营养不良症的遗传控制
- 批准号:
7498940 - 财政年份:2007
- 资助金额:
$ 75.12万 - 项目类别:
相似海外基金
Understanding the metabolic consequences of the systemic alanine depletion in pancreatic ductal adenocarcinoma
了解胰腺导管腺癌中全身丙氨酸消耗的代谢后果
- 批准号:
474506 - 财政年份:2022
- 资助金额:
$ 75.12万 - 项目类别:
Studentship Programs
Biosynthesis of bet-alanine in autolysosomes.
自溶酶体中 β-丙氨酸的生物合成。
- 批准号:
22K08681 - 财政年份:2022
- 资助金额:
$ 75.12万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Characterizing alanine transporters as therapeutic targets for pancreatic cancer
将丙氨酸转运蛋白描述为胰腺癌的治疗靶点
- 批准号:
466496 - 财政年份:2021
- 资助金额:
$ 75.12万 - 项目类别:
Studentship Programs
Understanding the requirements of alanine supply and demand in pancreatic ductal adenocarcinoma
了解胰腺导管腺癌中丙氨酸的供需要求
- 批准号:
451838 - 财政年份:2021
- 资助金额:
$ 75.12万 - 项目类别:
Operating Grants
Sensing living P. aeruginosa using D-alanine derived radiotracers
使用 D-丙氨酸衍生的放射性示踪剂感测活的铜绿假单胞菌
- 批准号:
10230924 - 财政年份:2021
- 资助金额:
$ 75.12万 - 项目类别:
Sensing living P. aeruginosa using D-alanine derived radiotracers
使用 D-丙氨酸衍生的放射性示踪剂感测活的铜绿假单胞菌
- 批准号:
10399593 - 财政年份:2021
- 资助金额:
$ 75.12万 - 项目类别:
Sensing living P. aeruginosa using D-alanine derived radiotracers
使用 D-丙氨酸衍生的放射性示踪剂感测活的铜绿假单胞菌
- 批准号:
10570987 - 财政年份:2021
- 资助金额:
$ 75.12万 - 项目类别:
Spot measurement of alanine radicals produced by irradiation and application of sugar radial to dosimeter
辐照产生的丙氨酸自由基的点测及糖自由基在剂量计中的应用
- 批准号:
19K05343 - 财政年份:2019
- 资助金额:
$ 75.12万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Metabolic significance of lysosomal beta-alanine
溶酶体β-丙氨酸的代谢意义
- 批准号:
18K08528 - 财政年份:2018
- 资助金额:
$ 75.12万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of dosimetry technique for IMRT using alanine dosimeter
使用丙氨酸剂量计开发 IMRT 剂量测定技术
- 批准号:
18K15615 - 财政年份:2018
- 资助金额:
$ 75.12万 - 项目类别:
Grant-in-Aid for Early-Career Scientists














{{item.name}}会员




